BerGenBio ASA (BRRGF) Stock Statistics & Valuation Metrics

BerGenBio ASA has a market cap or net worth of $6.44M. The enterprise value is $220.33M.

BerGenBio ASA has 39,087,116 shares outstanding. The number of shares has decreased by -2.65% in one year.

BerGenBio ASA’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -122.44%.

The current PE Ratio of BerGenBio ASA is -2.07. BerGenBio ASA’s PEG ratio is 0.03.

In the last 12 months, BerGenBio ASA had revenue of 848.00K and earned -139.28M in profits. Earnings per share was -3.95.

In the last 12 months, operating cash flow was -153.20M and capital expenditures 0.00, giving a free cash flow of -153.20M billion.

BerGenBio ASA pays an annual dividend of ―, resulting in a dividend yield of ―

BerGenBio ASA upcoming earnings date is May 21, 2025, TBA Not Confirmed.

BerGenBio ASA as a current ratio of 4.79, with Debt / Equity ratio of 0.67%

In the past 12 months, BerGenBio ASA has paid 0.00 in taxes.

BerGenBio ASA EV to EBITDA ratio is -1.11, with an EV/FCF ratio of -0.97.

BerGenBio ASA has $140.16M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -$139.34M billion.

Gross margin is -1952.12%, with operating margin of -17834.20%, and net profit margin of -16424.76%.

The average price target for BerGenBio ASA is $3.41, which is 11.43% higher than the current price. The consensus rating is Moderate Buy